Suppr超能文献

用于缓解胆囊癌的内镜下胆道内支架置入术

Endoscopic biliary endoprosthesis for palliation of gallbladder carcinoma.

作者信息

Vij J C, Govil A, Chaudhary A, Gulati R, Mehta S, Ganguli S

机构信息

Department of Gastroenterology, G.B. Pant Hospital, New Delhi, India.

出版信息

Gastrointest Endosc. 1996 Feb;43(2 Pt 1):121-3. doi: 10.1016/s0016-5107(06)80112-4.

Abstract

BACKGROUND

Carcinoma of the gallbladder is a major cause of malignant obstructive jaundice in India. It usually presents at an advanced stage and endoscopic palliation is the mainstay of treatment. We prospectively studied our results with endoscopic stenting in patients with carcinoma of the gallbladder.

METHODS

Patients unfit for surgery were included in the study. Straight 10F plastic prostheses were placed endoscopically. Patients were assessed for procedure success, early and late complications, and stent patency.

RESULTS

The success rate of stent placement was 84% (27 of 32). The five failures were caused by an inability to pass the guide wire across the stricture. Relief of pruritus and reduction in jaundice was seen in 25 of 27 (92%) patients. Double stents were placed in three patients. Four patients (11%) developed cholangitis in the first 30 days. Stent occlusion was detected in four patients after longer follow-up. The 30-day mortality was 5 of 27 (18%). There were no procedure-related deaths.

CONCLUSION

Endoscopic endoprosthesis is a safe and relatively effective palliative measure for the majority of patients with unresectable carcinoma of the gallbladder.

摘要

背景

在印度,胆囊癌是恶性梗阻性黄疸的主要病因。它通常在晚期出现,内镜下姑息治疗是主要的治疗方法。我们对胆囊癌患者内镜支架置入的结果进行了前瞻性研究。

方法

研究纳入了不适合手术的患者。通过内镜放置直的10F塑料支架。评估患者的手术成功率、早期和晚期并发症以及支架通畅情况。

结果

支架置入成功率为84%(32例中的27例)。5例失败是由于导丝无法穿过狭窄部位。27例患者中有25例(92%)瘙痒缓解、黄疸减轻。3例患者置入了双支架。4例患者(11%)在最初30天内发生胆管炎。经过更长时间的随访,4例患者检测到支架闭塞。27例患者中有5例(18%)在30天内死亡。无手术相关死亡。

结论

对于大多数无法切除的胆囊癌患者,内镜下置入假体是一种安全且相对有效的姑息治疗措施。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验